The Efficacy of Oral Steroids in the Treatment of Acute Sciatica
Oral Steroids in the Treatment of Acute Sciatica A Randomized Controlled Study
Sponsor: Kaiser Permanente
Listed as NCT00317447, this PHASE3 trial focuses on Sciatica and remains completed. Sponsored by Kaiser Permanente, it has been updated 4 times since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jan 2017 — Jan 2021 [monthly]
Completed PHASE3
First recorded
Feb 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Kaiser Permanente
For direct contact, visit the study record on ClinicalTrials.gov .